Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation

Takaaki KonumaDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, JapanCorrespondence[email protected]

Seiko KatoDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Jun OoiDepartment of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan

Yasuhiro EbiharaDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Shinji MochizukiDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Hiroto IshiiDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Tomomi TakeiDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Maki Oiwa-MonnaDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Arinobu TojoDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Satoshi TakahashiDepartment of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

show all

Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Second allogeneic transplantation using unrelated cord blood for relapsed hematological malignancies after allogeneic transplantation

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date